Register entry

Scienture LLC

Data as of · How to read this entry

Registered sites
0
Active NDC listings
2
Live patents
5
Exclusivities
1
Countries
0
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.

Dosage formNDCs
spray1
suspension1
RouteNDCs
nasal1
oral1
Labeller name on the listingNDCs
scienture llc2
Exclusivity

Patents and exclusivities

5
PatentProductCoversExpiry
12514854REZENOPYnaloxone hydrochlorideuseFeb 2041
12622903REZENOPYnaloxone hydrochlorideproductFeb 2041
11890273ARBLIlosartan potassiumproductOct 2041
12156869ARBLIlosartan potassiumproductOct 2041
12605365ARBLIlosartan potassiumproductOct 2041
ProductExclusivityUntil
REZENOPYNALOXONE HYDROCHLORIDENP New productApr 2027
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
ARBLIlosartan potassiumsuspension, oral83245-053NDA
REZENOPYnaloxone HClspray, nasal83245-003NDA
Compare

Other companies listing losartan potassium

Enquiry

Common questions

Is Scienture LLC FDA approved?
Scienture LLC holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Scienture LLC make?
2 products are listed under Scienture LLC in the openFDA NDC Directory, most often as spray; suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.